This is a single-institution, non-randomized phase 1/2 study in patients with locally-advanced or metastatic NSCLC in remission after receiving standard systemic chemotherapy of four cycles of combination chemotherapy consisting of four cycles of cisplatin combined with vinorelbine.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients in remission after first-line chemotherapy
You may not be if
Progressive disease
Clareo Health | Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer
